Harvest Investment Services, LLC Protagonist Therapeutics, Inc Transaction History

Harvest Investment Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $794,916 - $1.3 Million	44,113 New	44,113 $1.22 Million
Q2 2022 Jul 19, 2022	SELL	$7.06 - $25.52 $94,335 - $340,998	-13,362 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$23.34 - $36.08 $122,885 - $189,961	-5,265 Reduced 28.27%	13,362 $316,000
Q4 2021 Jan 31, 2022	SELL	$17.63 - $37.1 $40,196 - $84,588	-2,280 Reduced 10.91%	18,627 $637,000
Q3 2021 Oct 29, 2021	BUY	$12.95 - $49.69 $270,745 - $1.04 Million	20,907 New	20,907 $370,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.